TNF Pharmaceuticals stockholders approve 2.26M share increase to equity plan

Q/C TECHNOLOGIES, INC.

Stockholders re-elected all seven director nominees: Glass, Eagle, Schreiber, Silverman, Uzonwanne, White, Friscia.
Equity plan share reserve increased by 2,259,060 to 2,500,000 total, approved with 2.92M for and 116K against.
Stephano Slack LLC ratified as independent auditor for FY 2024 with 3.74M votes for.
Adjournment proposal approved with 3.42M votes for to permit further solicitation if needed.
Voting results final; no other matters considered at the annual meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.